78
Participants
Start Date
November 8, 2010
Primary Completion Date
February 13, 2015
Study Completion Date
February 13, 2015
Panitumumab + FOLFOX (DP)
Panitumumab and FOLFOX will be administered to patients with DP once every 14 days until 6 months of treatment or until disease progression (PD) or unacceptable toxicity. If patients have not progressed after 6 months of treatment with panitumumab and FOLFOX they will continue with panitumumab monotherapy until disease progression.
Panitumumab + FOLFOX (no-DP)
Panitumumab and FOLFOX will be administered to patients with no-DP (MMP7+/p-IGF-IR-, MMP7-/p-IGF-IR+ or MMP7-/p-IGF-IR) once every 14 days until 6 months of treatment or until disease progression (PD) or unacceptable toxicity. If patients have not progressed after 6 months of treatment with panitumumab and FOLFOX they will continue with panitumumab monotherapy until disease progression.
Consorcio Hospitalario Provincial de Castellon, Castellon
Hospital General de Ciudad Real, Ciudad Real
Centro Oncológico de Galícia, A Coruña
Institut Català d'Oncologia (ICO) de Girona, Girona
Hospital Arnau de Vilanova de Lleida, Lleida
Hosptial de Logroño, Logroño
Hospital Universitario La Paz de Madrid, Madrid
Hospital Infanta Sofía de Madrid, Madrid
Hospital Universitario Puerta de Hierro de Madrid, Madrid
Hospital de Fuenlabrada de Madrid, Madrid
Hospital Morales Meseguer, Murcia
Clínica Universitaria de Navarra, Pamplona
Hospital de Navarra, Pamplona
Hosptial Dr. Negrin de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria
Hospital Xeral Cies de Vigo, Vigo
Hosptial de Sant Pau i Santa Tecla de Tarragona, Tarragona
Hospital La Fe de Valencia, Valencia
Instituto Valenciano de Oncología de Valencia, Valencia
Hospital General de Valencia, Valencia
Hospital Dr. Peset de Valencia, Valencia
Hospital Miguel Servet de Zaragoza, Zaragoza
Hospital General Universitario de Elche, Elche
Hospital Son Espases de Mallorca, Palma de Mallorca
Hosptial Son Llatzer de Mallorca, Palma de Mallorca
Hosptial General de l'Hospitalet de Barcelona, L'Hospitalet de Llobregat
Corporació Sanitaria Parc Taulí de Barcelona, Sabadell
Hospital de l'Esperit Sant, Santa Coloma de Gramenet
Hospital Clínic i Provincial de Barcelona, Barcelona
Hospital de la Santa Creu i Sant Pau de Barcelona, Barcelona
Complejo Asitencia de Burgos. Hospital General Yague, Burgos
Collaborators (1)
Amgen
INDUSTRY
TFS Trial Form Support
INDUSTRY
Grupo Espanol Multidisciplinario del Cancer Digestivo
OTHER